131 related articles for article (PubMed ID: 4593243)
21. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli.
Svennerholm AM; Holmgren J; Black R; Levine M; Merson M
J Infect Dis; 1983 Mar; 147(3):514-22. PubMed ID: 6339647
[TBL] [Abstract][Full Text] [Related]
22. Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease.
Sack RB; Gorbach SL; Banwell JG; Jacobs B; Chatterjee BD; Mitra RC
J Infect Dis; 1971 Apr; 123(4):378-85. PubMed ID: 4938945
[No Abstract] [Full Text] [Related]
23. Antibody cross-reactions with lipopolysaccharide from E. coli O157 after cholera vaccination.
Chart H; Rowe B
Lancet; 1993 May; 341(8855):1282. PubMed ID: 8098423
[No Abstract] [Full Text] [Related]
24. Escherichia coli serotypes associated with urinary tract infections in the Western Cape.
Brede HD; Coldrey NA; Coates JK; Finlayson MH
S Afr Med J; 1974 Feb; 48(7):261-3. PubMed ID: 4592323
[No Abstract] [Full Text] [Related]
25. Serological studies in cholera infection in Calcutta (1966-67).
Deb BC; Ganguly R; Sinho R; Ghosh AK; Succar BK; Abou-Gareeb AH; Ozawa A; Shrivastava DL; Burrows W
Indian J Med Res; 1973 Feb; 61(2):169-78. PubMed ID: 4758991
[No Abstract] [Full Text] [Related]
26. Challenge of dogs with live enterotoxigenic Escherichia coli and effects of repeated challenges on fluid secretion in jejunal Thiry-Vella loops.
Sack RB; Johnson J; Pierce NF; Keren DF; Yardley JH
J Infect Dis; 1976 Jul; 134(1):15-24. PubMed ID: 781145
[TBL] [Abstract][Full Text] [Related]
27. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
[TBL] [Abstract][Full Text] [Related]
28. Studies on immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae.
Singh A; Mohan KS; Sethi SK
Indian J Med Res; 1977 Jun; 65(6):777-81. PubMed ID: 342403
[No Abstract] [Full Text] [Related]
29. Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli.
Sack RB; Froehlich JL
J Clin Microbiol; 1977 Jun; 5(6):570-2. PubMed ID: 69630
[TBL] [Abstract][Full Text] [Related]
30. Comparison of paired whole milk and dried filter paper samples for anti-enterotoxin and anti-rotavirus activities.
Brown SE; Sauer KT; Nations-Shields M; Shields DS; Araujo JG; Guerrant RL
J Clin Microbiol; 1982 Jul; 16(1):103-6. PubMed ID: 6286715
[TBL] [Abstract][Full Text] [Related]
31. Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization.
Pierce NF; Reynolds HY
J Immunol; 1974 Sep; 113(3):1017-23. PubMed ID: 4413777
[No Abstract] [Full Text] [Related]
32. Characterization of the Chinese hamster ovary cell assay for the enterotoxins of Vibrio cholerae and Escherichia coli and for specific antisera, and toxoid.
Guerrant RL; Brunton LL
J Infect Dis; 1977 May; 135(5):720-8. PubMed ID: 323378
[TBL] [Abstract][Full Text] [Related]
33. Diarrhoea resembling cholera induced by Escherichia coli culture filtrate.
Nalin DR; Richardson SH; Bhattacharjee AK
Lancet; 1973 Apr; 1(7808):885. PubMed ID: 4123431
[No Abstract] [Full Text] [Related]
34. Serum antibody against heat-labile enterotoxin of Escherichia coli in pigs.
Akaike Y; Ogawa T; Miyachi T; Sugawara M; Isayama Y; Kashiwazaki M
Natl Inst Anim Health Q (Tokyo); 1981; 21(1):61-2. PubMed ID: 7017425
[No Abstract] [Full Text] [Related]
35. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
36. [Method of preparation of erythrocytic diagnostic agents for detection of antitoxic and antibacterial antibodies in El Tor cholera].
Tsybin BP; Taran IF
Lab Delo; 1975; (3):170-2. PubMed ID: 48596
[No Abstract] [Full Text] [Related]
37. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
38. The production of diarrhoea in baby rabbits by the oral administration of cell-free preparations of enteropathogenic Escherichia coli and Vibrio cholerae: the effect of antisera.
Smith HW
J Med Microbiol; 1972 Aug; 5(3):299-303. PubMed ID: 4560748
[No Abstract] [Full Text] [Related]
39. [Prophylactic immunization against enterotoxin-forming Escherichia coli travellers' diarrhea and cholera: does it make sense and for whom?].
Weinke T; Liebold I; Burchard GD; Frühwein N; Grobusch MP; Hatz C; Kollaritsch H; Nothdurft HD; Reisinger E; Rieke B; Schönfeld Ch; Steffen R; Stich A
Dtsch Med Wochenschr; 2006 Jul; 131(30):1660-4. PubMed ID: 16850383
[No Abstract] [Full Text] [Related]
40. Neutralizing antibodies against Escherichia coli and Vibrio cholerae enterotoxins in human milk from a developing country.
Holmgren J; Hanson LA; Carlson B; Lindblad BS; Rahimtoola J
Scand J Immunol; 1976; 5(6-7):867-71. PubMed ID: 790543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
